The trial is tied to a post-marketing commitment that FDA Commissioner Martin Makary put in place last year for all approved ...

A new Lyme disease vaccine made by Pfizer and Valneva could lower infection rates of the tick-borne illness, but federal ...

Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, a lackluster result as fewer-than-expected infections in the pivotal study made its potency ...

In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug ...

Nearly half a million people are diagnosed and treated for Lyme disease in the U.S. every year, and Pennsylvania is a hot bed ...

Vaccine maker's critics hope for new attorney general to reverse Pam Bondi's hostility to clinical trial whistleblower's ...

By Bhanvi Satija LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated ...

Michigan has seen cases skyrocket 168% in five years, but the new vaccine candidate offers hope with strong trial results and ...

A new vaccine to prevent Lyme disease in humans may soon be available. Pfizer said it's planning to seek regulatory approval.

Poland and Romania have been ordered by a Belgian court to pay Pfizer Inc. €1.9 billion ($2.2 billion) for Covid-19 vaccines ...